News Related to Cardiogenic Shock

Related coverage linked through entity extraction aliases.

NICE Updates Type 2 Diabetes Guidance for Earlier SGLT-2 Inhibitor Use; SGLT2 Inhibitors Also Linked to Survival Benefit in Takotsubo Syndrome

May 28, 2026

NICE updates type 2 diabetes guidance in England, recommending earlier use of SGLT-2 inhibitors and GLP-1 receptor agonists. Separately, a study finds SGLT2 inhibitors improve survival in Takotsubo syndrome patients.

Cancer Survivorship Brings Long-Horizon Focus to Heart Health

May 04, 2026

More cancer survivors are living long enough to face lasting cardiovascular effects of treatment. Cardio-oncology clinics are managing heart failure, valvular disease and radiation-related heart disease.